Induction Immunosuppressive Therapy

Ali H. Charafeddine, Allan D. Kirk

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

Immunomodulatory regimens used for organ transplantation can be generally classified as induction, maintenance, or rescue therapies. Induction therapy is intense, prophylactic therapy used at the time of transplantation based on the empiric observation that the early requirements for immunomodulation exceed those late after transplantation. In general, the intensity of induction regimens is such that prolonged exposure is prohibitively toxic. However, when used appropriately, induction can reduce the incidence of acute rejection and simplify the early immune management of transplant recipients. They have not been convincingly shown to improve long-term outcomes and, as such, their clinical use remains largely based on institutional preference. This chapter will cover the emerging biological basis for induction therapy, review the common regimens used for this purpose, and provide reference to those trials elucidating their role in transplantation.

Original languageEnglish
Title of host publicationTextbook of Organ Transplantation
Subtitle of host publicationVolume 1-2
Publisherwiley
Pages715-731
Number of pages17
Volume1-2
ISBN (Electronic)9781118873434
ISBN (Print)9781118889626
DOIs
StatePublished - 1 Jan 2014
Externally publishedYes

Keywords

  • clinical research/practice
  • immunosuppressant: fusion proteins and monoclonal antibodies
  • Immunosuppressant: polyclonal preparations
  • immunosuppressant: steroid
  • immunosuppression/immune modulation
  • immunosuppressive regimens: induction

Cite this